-
Changes in Respiratory Medication and Antibiotic Use Among Asthma and COPD Individuals During the Pandemic
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis of Migraine Prevention Treatments for Chronic Migraine Headaches Patients in the United States
Mar 10, 2025, 14:00 PM -
Healthcare Resource Use in Commercially- and Medicaid-Insured Infants, Toddlers, and Children Diagnosed With Invasive Meningococcal Disease in the United States
Mar 10, 2025, 14:00 PM -
Patient Reported Outcomes in BRUIN CLL-321: A Phase 3 Trial of Pirtobrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Mar 10, 2025, 14:00 PM -
Diffusion and Launch Sequencing of Cell and Gene Therapies across the USA, Europe, Canada and Australia
Mar 10, 2025, 14:00 PM -
Use of Patient Support Program Data for Real-World Evidence Generation: Opportunities and Pitfalls Illustrated in a Case Study Assessing Trastuzumab Deruxtecan Among Patients With Breast Cancer
Mar 10, 2025, 14:00 PM -
Early Germline BRCA Testing in Breast Cancer: A Review of Value Frameworks and Cost-Effectiveness Analyses
Mar 10, 2025, 14:00 PM -
Adjusted Comparison of Amivantamab in Combination With Carboplatin Plus Pemetrexed From the PAPILLON Study Versus US Real-World Frontline Treatments in Patients With Advanced NSCLC Harboring EFGR Exon 20 Insertions
Mar 10, 2025, 14:00 PM -
A Systematic Literature Review on Symptom Burden and Impact of Disease on Quality of Life in Patients With Essential Thrombocythemia
Mar 10, 2025, 14:00 PM -
Economic Evaluation of Detection, Treatment, and Prevention Interventions for Perinatal Mood and Anxiety Disorders: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Assessing Disease Severity: How HTA Bodiea Evaluate Unmet Needs and Influemce Decision-Making
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns, Healthcare Costs and Resource Utilization in First-Line Treatment of Metastatic NSCLC in the US using MarketScan® data
Mar 10, 2025, 14:00 PM -
Frailty Indices Using Claims Data - Examples from a Hospitalized Medicare Population
Mar 10, 2025, 14:00 PM -
Real World Treatment Patterns, Genetic Testing, and Clinical Outcomes among Patients with mCRPC Treated with Olaparib Monotherapy in US Urology Clinics
Mar 10, 2025, 14:00 PM -
Trial-Based Economic Evaluation of 'Partner in Balance,' a Blended Self-management Program for Early-Stage Dementia Caregivers in the Netherlands: The Health-Economic Analysis Plan and Baseline Results
Mar 10, 2025, 14:00 PM -
Changes in HbA1c and Body Weight in US Adults With Type 2 Diabetes and Chronic Kidney Disease Who Received Oral Semaglutide
Mar 10, 2025, 14:00 PM -
Temporal Trends in Prescription of GLP-1RAs for Weight Loss: Insights From a Five-Year Retrospective Analysis in the US
Mar 10, 2025, 14:00 PM -
Real-World Economic and Clinical Burden of Worsening Heart Failure in the US: Administrative Claims Database Analysis
Mar 10, 2025, 14:00 PM -
Population Impact Model of Faricimab and Aflibercept 8mg among US patients with Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
Mar 10, 2025, 14:00 PM -
The HER2-TRENDS StudyHR Positive - HER2 Negative Metastatic Breast Cancer (mBC) Treatment Patterns and Clinical Outcomes in Canada
Mar 10, 2025, 14:00 PM
